Markets:

Overview

News

Currencies

International

Treasuries

Quest Diagnostics (NY:DGX)

207.85 -1.47 (-0.70%)

Streaming Delayed Price Updated: 2:48 PM EST, Feb 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

2 Dividend Stocks That Recently Boosted Their Payouts by More Than 7% ↗

February 15, 2023

These companies may not be finished raising their dividend payments as they both have low payout ratios.

Via The Motley Fool

5 Analysts Have This to Say About Quest Diagnostics ↗

January 23, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 23, 2023 ↗

January 23, 2023

Via Benzinga

Analyst Ratings for Quest Diagnostics ↗

January 06, 2023

Via Benzinga

Where Quest Diagnostics Stands With Analysts ↗

December 14, 2022

Via Benzinga

Golden Cross Appears Before Quest Diagnostics Investors ↗

November 28, 2022

Via Benzinga

Where Quest Diagnostics Stands With Analysts ↗

November 17, 2022

Via Benzinga

Why Quest Diagnostics Stock Jumped Today ↗

October 20, 2022

Growth in the lab testing titan's core business is accelerating.

Via The Motley Fool

Down 40% in 2022, Can Exact Sciences Recover in 2023? ↗

January 23, 2023

Investors are attracted to its leading position in the market for early cancer detection, but the persistent losses its been reporting are enough to make anyone nervous.

Via The Motley Fool

These 2 Defensive Plays Are Highlights Of CNBC's 'Final Trades' ↗

December 23, 2022

On CNBC’s "Halftime Report: Final Trades," Shannon Saccocia of Boston Private said Quest Diagnostics Inc (NYSE: DGX) is expected to grow 4% to 5%

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 01, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Quest Diagnostics To Plunge 16%? Here Are 5 Other Price Target Changes For Thursday ↗

November 17, 2022

Via Benzinga

DermTech and Sonora Quest Laboratories Expand Access to Innovative Melanoma Detection Test

November 15, 2022

From DermTech, Inc.

Via Business Wire

Quest Diagnostics Q3 Earnings Surpass Expectations, Raises Annual Guidance ↗

October 20, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022 ↗

November 17, 2022

Upgrades

Via Benzinga

Here’s Why Quest Diagnostics Stock Should Be in Your Portfolio

October 31, 2022

Medical diagnostic lab company Quest Diagnostic (NYSE: DGX) stock has been trading within a boxed range from $126 to $146 for the majority of 2022.

Via MarketBeat

Quest Diagnostics: Q3 Earnings Insights ↗

October 20, 2022

Quest Diagnostics (NYSE:DGX) reported its Q3 earnings results on Thursday, October 20, 2022 at 06:45 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For October 20, 2022 ↗

October 20, 2022

Companies Reporting Before The Bell • ABB (NYSE:ABB) is estimated to report quarterly earnings at $0.38 per share on revenue of $7.35 billion.

Via Benzinga

A Preview Of Quest Diagnostics's Earnings ↗

October 19, 2022

Quest Diagnostics (NYSE:DGX) is set to give its latest quarterly earnings report on Thursday, 2022-10-20. Here's what investors need to know before the announcement. Analysts estimate that Quest...

Via Benzinga

Eli Lilly, EQT, Cash Cows ETF, Northrop Grumman And This Diagnostics Company Feature On CNBC's Final Trade ↗

October 03, 2022

On CNBC’s “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management said Pacer US Cash Cows 100 ETF (BATS: COWZ) is “a factor-b

Via Benzinga

What Fast Food And Entertainment Giants Did Traders Pick For CNBC's Fast Money Call Of The Day ↗

September 30, 2022

CNBC’s "Fast Money Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned. The information is collected and refined...

Via Benzinga

FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests ↗

September 27, 2022

Via Benzinga

COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns ↗

September 23, 2022

The World Health Organization (WHO) warned that it struggles to identify and

Via Benzinga

Achievers and Quest Diagnostics Win Gold in the 2022 Brandon Hall Group Excellence Technology Awards

September 14, 2022

From Achievers

Via Business Wire

Quest Becomes Exclusive Validator For Results From The Hound Cannabis Breathalyzer ↗

September 14, 2022

Hound Labs, creator of the Hound Cannabis Breathalyzer, entered into an agreement with Quest Diagnostics (NYSE: DGX), a provider of diagnostic information services.

Via Benzinga

No More Free COVID-19 At-Home Tests, Federal Government Says ↗

August 29, 2022

CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au

Via Benzinga

3 Top Monkeypox Stocks to Buy Right Now ↗

August 24, 2022

With cases of a frightening disease spreading to all 50 states, it’s now time to consider the top monkeypox stocks to buy right now.

Via InvestorPlace

3 Monkeypox Stocks to Buy as Biden Declares Public Health Emergency ↗

August 05, 2022

Monkeypox stocks are about to rise now that the White House has declared the virus a public health emergency. Here are the stocks to watch.

Via InvestorPlace

Drug Testing At Work Is A Thing Of The Past, Study Finds ↗

July 30, 2022

According to a study conducted by Quest Diagnostics Inc (NYSE: DGX), drug use among American employees, as measured by the percentage of employees who tested positive in urine drug tests, hit a

Via Benzinga

4 Analysts Have This to Say About Quest Diagnostics ↗

July 22, 2022

Analysts have provided the following ratings for Quest Diagnostics (NYSE:DGX) within the last quarter:

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Quest Diagnostics (NY:DGX)

All News about Quest Diagnostics

Starting at $3.75/week.

Subscribe Today